FARMOVS PAREXEL (Proprietary) Ltd.

What FARMOVS PAREXEL (Proprietary) Ltd. does

FARMOVS is a South African clinical research organization (CRO) and bioanalytical laboratory headquartered on the campus of the University of the Free State in Bloemfontein. Established in 1974 as the Pharmacology Research Unit and incorporated as FARMOVS (Pty) Ltd in 2000, the company provides integrated Phase I-IIa clinical trial services to global pharmaceutical and biotech clients. Since inception it has managed more than 3,000 clinical trials spanning bioequivalence, bioavailability, first-in-human (FIH), biosimilar, drug-drug interaction, food effect, SAD/MAD, and specialized PK/PD and biomarker studies, and currently operates from a 5,000 sqm facility with 96 beds across 4 wards, an 8-bed manual glucose clamp unit, 8 en-suite long-term admission rooms, and specialized medical equipment including a DEXA scanner, cardiovascular and respiratory laboratories, telemetry, and colposcope.

The company's core offering combines a clinical services division, a GLP-certified bioanalytical laboratory equipped with 15 LC-MS/MS systems (including the SCIEX Triple Quad 7500 for sub-picogram/ml quantification) and over 580 internally validated assay methods, an ISO 15189 accredited on-site clinical laboratory, an SAPC A-Grade institutional pharmacy with depot service, plus a dedicated immunochemistry laboratory (RIA, ELISA, ECL, MSD platforms with Hamilton STARLet robotics and BioTek readers), and a Site Management Organisation (SMO) division managing 50 investigator sites across South Africa. Supporting functions include project management, medical writing, regulatory services (SAHPRA submissions in roughly 8 weeks for bioequivalence and 12-14 weeks for CTC-reviewed studies), quality assurance, and international logistics with IATA-certified sample handling and World Courier transport.

FARMOVS monetizes primarily through professional-services fees for clinical research and bioanalytical work delivered on a quote basis, with billings to pharmaceutical, biotech, and other CRO clients (over 50% of bioanalytical sample volume comes from CROs outside South Africa). A secondary recurring revenue stream comes from accredited online GxP training courses (SA GCP Basic at R3,130, GCP Refresher at R2,050, and an upcoming GLP course at R1,200). Customer acquisition is enterprise B2B field sales supported by academic affiliation with the University of the Free State and a volunteer mailing list used for participant recruitment.

Name

FARMOVS PAREXEL (Proprietary) Ltd.

Legal name

FARMOVS (Pty) Ltd

Website

https://farmovs.com

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

101–250 employees

Short description

South African clinical research organization affiliated with the University of the Free State, providing integrated Phase I-IIa clinical trials, GLP-certified bioanalytical services, ISO 15189 clinical laboratory, and pharmacy support to global pharmaceutical and biotech clients.

Ownership category

akta.pro rank

Product category

Contract Research Organization Services

NAICS

Medical Laboratories (621511), Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industry

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)

Keywords

• Clinical research services
• Bioanalytical laboratory
• Phase I trials
• Bioequivalence studies
• Pharmaceutical contract research

Headquarters

HQ city

Bloemfontein

HQ country

South Africa

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Research Services (Full-Service and Standalone): FARMOVS provides integrated clinical research organization (CRO) services including bioanalysis, clinical services, pharmacy, project management, medical writing, regulatory services, SMO, logistics and sample handling, and quality assurance. Services are offered either as a holistic integrated solution or as standalone services that integrate into clients' existing workflows. Revenue is derived from service fees for managing and conducting clinical trials for pharmaceutical and biotech clients globally.
2. GCP and GLP Online Training Courses: FARMOVS offers accredited online Good Clinical Practice (SA GCP) courses and GLP courses for professionals seeking to enter or advance in clinical research. Courses are priced at R3,130 (basic GCP), R2,050 (refresher GCP), and R1,200 (GLP course), all including VAT. Revenue is generated through course enrollment fees.
3. Volunteer Recruitment and Clinical Trial Participation: FARMOVS recruits healthy volunteers and patients for clinical research trials, generating compensation revenue from study sponsors. Volunteers are compensated for inconvenience and costs incurred during participation.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

FARMOVS is a clinical research organization (CRO) providing integrated Phase I-IIa clinical trial services from a single site in Bloemfontein, South Africa. Its core offerings combine clinical trial conduct, GLP-certified bioanalytical laboratory services (LC-MS/MS drug, metabolite, and biomarker quantification), an SAPC-registered A-Grade on-site pharmacy, and an SMO network spanning 50 investigator sites. Services are delivered as an integrated full-service solution or as standalone offerings that integrate into clients' existing workflows.

Product overview

FARMOVS is a clinical research organization (CRO) offering an integrated portfolio of Phase I-IIa clinical research services from a single facility in Bloemfontein, South Africa. The core offering combines Clinical Services (patient populations across 12+ therapeutic areas), the Bioanalysis Division (GLP-certified laboratory with LC-MS/MS, 580+ validated methods), and Pharmacy Services (SAPC-registered, A-Grade rated). These are supported by Project Management, Medical Writing, Regulatory Services, SMO (50 network-investigator sites), Quality Assurance, Logistics & Sample Handling, and GxP training courses. The unified model allows clients to engage standalone services or a full-service integrated solution for bioequivalence studies, First-in-Human trials, and patient population studies.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Services

Quantifiable outcome

• 3,000+ clinical trials successfully managed and conducted since 1974
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered core.

• Universitas Academic Hospital - Adult Bleeding Disorder CliniccoreStrategic or Co-development Partner · 1 January 2021FARMOVS collaborated with the Adult Bleeding Disorder Clinic at Universitas Academic Hospital and UFS experts (Prof Marius Coetzee, Dr Jaco Joubert, Dr Leriska Haupt) to conduct a ground-breaking Phase 1 clinical trial investigating a new application of an existing drug in patients with haemophilia A. The study ran from January to July 2021 and was part of a global clinical research study.
• University of the Free State (UFS)coreStrategic or Co-development PartnerFARMOVS is affiliated with and operates on the campus of the University of the Free State in Bloemfontein, South Africa. The affiliation provides access to academic expertise, medical school collaboration, and proximity to Universitas Academic Hospital. FARMOVS collaborates with UFS researchers and contributes to clinical research innovation in central South Africa. The HSREC (Health Sciences Research Ethics Committee) of UFS reviews clinical trial applications.
• SMO Network (50 Investigator Sites)coreChannel Partner/ Reseller/ DistributorFARMOVS SMO division partners with 50 clinical research sites, including external sites with medical doctors, specialist physicians, hospitals, and dedicated research centres across all therapeutic areas. These partnerships extend reach to rural areas and treatment-naive participants.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Labcorp Drug Development (formerly Covance): Full-service CRO with embedded central and specialty laboratories providing bioanalytical and clinical pharmacology services. Direct competitor in early-phase clinical and bioanalytical markets.
• Parexel International: Global full-service CRO offering Phase I-IV clinical development, bioanalysis, and regulatory services across all major geographies. The 'PAREXEL' suffix in FARMOVS' legal name suggests a strategic commercial relationship; both compete for the same sponsor Phase I work.
• Charles River Laboratories: CRO with strong bioanalytical and early-phase clinical capabilities, including the former CRL Preclinical and Clinical divisions. Closely comparable in early-phase clinical pharmacology and bioanalytical assay services.
• ICON plc: Global CRO providing clinical research, bioanalytical, and laboratory services across all phases. Competes head-to-head with FARMOVS for Phase I-IIa engagements and large pharma outsourcing programs.
• Medpace: Mid-sized global CRO focused on Phase II-IV clinical trials with strong bioanalytical and clinical pharmacology capabilities. Competes with FARMOVS for outsourced Phase I-IIa work from small to mid-sized biotech.
• Syneos Health: Global biopharma services organization offering clinical and bioanalytical solutions. Overlaps with FARMOVS in early-phase trial execution and bioanalytical support for global sponsors.
• Frontage Laboratories: CRO providing bioanalytical, CMC, and early-phase clinical services with operations in the US and China. Comparable bioanalytical assay capabilities and Phase I clinical research model to FARMOVS.
• Celerion: Specialty CRO focused on early-phase clinical pharmacology, bioequivalence, and bioanalytical services. Closely comparable niche positioning to FARMOVS in Phase I and bioanalytical markets.

Broad incumbents

• WuXi AppTec: Global CRO/CDMO with extensive bioanalytical and clinical operations across Asia, US, and Europe. Comparable in bioanalytical and Phase I capabilities, with broader scale and geographic reach than FARMOVS.
• IQVIA: Largest global CRO with full Phase I-IV capabilities, central laboratories, and integrated technology platforms. Overlaps with FARMOVS in Phase I and bioanalytical services but at vastly greater scale and geographic footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/farmovs

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FARMOVS PAREXEL (Proprietary) Ltd.